Abstract
Fidaxomicin (FDX) is a marketed antibiotic for the treatment of Clostridioides difficile infections (CDI). Fidaxomicin displays antibacterial properti......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
